Massachusetts Joint Joint Committee on Health Care Financing [?] | Senate | Bills

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
MAS2520Engross
50%
Relative to pharmaceutical access, costs and transparency
[Detail][Text][Discuss]
2024-07-25
Committee of conference appointed - (Lawn-F. Moran-Barrows), in concurrence
MAS2842Intro
25%
Relative to non-opioid alternatives in pain treatment report the accompanying Order (Senate, No. 2842).
[Detail][Text][Discuss]
2024-07-18
To Senate Rules Committee
MAS2795Intro
25%
Relative to emergency medical services oversight (Senate, No. 2739); and to improve oral health for all Massachusetts residents (Senate, No. 2795) , reports the accompanying Order (Senate, No. 2795).
[Detail][Text][Discuss]
2024-06-06
To Senate Rules Committee
MAS2768Intro
25%
Relative to community behavioral health centers (Senate, No. 613); and ensuring prompt access to health care (Senate, No. 654) , reports the accompanying Order (Senate, No. 2768).
[Detail][Text][Discuss]
2024-05-16
To Senate Rules Committee
MAS2748Intro
25%
Relative to emergency insulin access (Senate, No. 651); and to increase health insurance affordability for small business (Senate, No. 1899), reports the accompanying Order (Senate, No. 2748).
[Detail][Text][Discuss]
2024-04-29
To Senate Rules Committee
MAS2733Intro
25%
For legislationfor legislationfor legislationfor legislationfor legislationfor legislationfor legislationfor legislationfor legislation to prevent undue influence on prescriber behavior, report the accompanying Order (Senate, No. 2733).
[Detail][Text][Discuss]
2024-04-25
To Senate Rules Committee
MAS2492Intro
25%
For legislationfor legislationfor legislationfor legislationfor legislationfor legislationfor legislation to bring down the cost of prescription drugs; of Nicholas A. Boldyga relative to establishing a prescription drug rebate program for seniors; of...
[Detail][Text][Discuss]
2023-11-15
Read second
MAS2499Intro
25%
Relative to pharmaceutical access, costs and transparency
[Detail][Text][Discuss]
2023-11-15
Bills in the Third Reading report, substituting a new draft S2520, accepted
Syndicate content
feedback